APA (7th ed.) Citation

CH, Z., KA, S., RA, R., K, H., EA, S., JA, I., . . . WL, J. (2021). Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency. ACS medicinal chemistry letters, 12(8), 1325. https://doi.org/10.1021/acsmedchemlett.1c00326

Chicago Style (17th ed.) Citation

CH, Zhang, et al. "Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency." ACS Medicinal Chemistry Letters 12, no. 8 (2021): 1325. https://doi.org/10.1021/acsmedchemlett.1c00326.

MLA (9th ed.) Citation

CH, Zhang, et al. "Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency." ACS Medicinal Chemistry Letters, vol. 12, no. 8, 2021, p. 1325, https://doi.org/10.1021/acsmedchemlett.1c00326.